Malignancy after liver transplantation: cumulative risk for development.

Area of Science:

• Oncology
• Transplantation Medicine
• Epidemiology

Background:

• Solid organ recipients are a high-risk group for developing malignancies.
• These cancers represent a major cause of late mortality following transplantation.
• Understanding cancer incidence post-transplant is crucial for patient management.

Purpose of the Study:

• To determine the cumulative incidence and types of malignancies in adult liver transplant recipients.
• To assess long-term cancer risk following orthotopic liver transplantation (OLT).
• To inform surveillance strategies for post-transplant cancer.

Main Methods:

• Retrospective cohort study of adult liver transplant recipients (1986-2002).
• Minimum follow-up of 36 months.
• Kaplan-Meier method used for cumulative risk and survival analyses.

Main Results:

• 98 out of 528 patients developed cancer; 25% were skin malignancies.
• Cumulative risk for noncutaneous malignancies at 5, 10, and 15 years was 9%, 18%, and 25%, respectively.
• Common noncutaneous malignancies included posttransplant lymphoproliferative disease, lung, Kaposi's sarcoma, genitourinary, and oropharyngeal/laryngeal cancers.

Conclusions:

• Orthotopic liver transplantation recipients have a substantially elevated risk of developing malignancies.
• The cumulative risk of noncutaneous malignancies reaches 25% by 15 years post-transplantation.
• Implementation of long-term surveillance and screening programs is essential for selected patient groups.